Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 21, 2025 10:00 ET | Source: SPR Therapeutics, Inc.

SPRINT® PNS Meets Primary Endpoint of Reduction in Head Pain in First Publication of Multicenter Prospective MONARCH™ Study

SPRINT® PNS meets the primary endpoint of reduction in head pain in the first publication of multicenter prospective MONARCH™ Study.